← back to search

Marco Colizzi

University of Udine · IT
Area of research
Pharmacology · Clinical Psychology
Research interest
Research interests include Cannabis and Cannabinoid Research, Autism Spectrum Disorder Research, COVID-19 and Mental Health, and Schizophrenia research and treatment.
h-index
35
citations
5,250
works
167
NIH funding
primary concept
email

Recent publications

In Web We Trust: The Promised Cannabidiol Effects on Obesity as a Matter of Language and Marketing on Webpages
Current Neuropharmacology 2025cited by 0position: middledoi
Where Do Neurodevelopmental Disorders Go? Casting the Eye Away from Childhood towards Adulthood
Healthcare 2023cited by 59position: lastdoi
Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence
Frontiers in Psychiatry 2022cited by 31position: firstdoi
Gender-Oriented Mental Health Prevention: A Reappraisal
International Journal of Environmental Research and Public Health 2022cited by 26position: lastdoi
Effectiveness of Equine-Assisted Activities and Therapies for Improving Adaptive Behavior and Motor Function in Autism Spectrum Disorder
Journal of Clinical Medicine 2021cited by 33position: lastdoi
Psychosocial and Behavioral Impact of COVID-19 in Autism Spectrum Disorder: An Online Parent Survey
Brain Sciences 2020cited by 559position: firstdoi
Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report
Brain Behavior & Immunity - Health 2020cited by 146position: firstdoi
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
Psychopharmacology 2020cited by 92position: middledoi
Should we be concerned about stigma and discrimination in people at risk for psychosis? A systematic review
Psychological Medicine 2020cited by 86position: firstdoi
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
Frontiers in Psychiatry 2020cited by 79position: middledoi
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis
Psychological Medicine 2020cited by 76position: middledoi
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
Frontiers in Psychology 2020cited by 50position: firstdoi
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study
Schizophrenia Research 2020cited by 40position: middledoi
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
Molecular Psychiatry 2019cited by 80position: firstdoi
Differential gene expression analysis in blood of first episode psychosis patients
Schizophrenia Research 2019cited by 43position: middledoi
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids
Psychological Medicine 2019cited by 24position: middledoi
The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task
Neuropsychology Review 2018cited by 202position: middledoi
Cannabis use and the development of tolerance: a systematic review of human evidence
Neuroscience & Biobehavioral Reviews 2018cited by 168position: firstdoi
Cannabis and psychosis: what do we know and what should we do?
The British Journal of Psychiatry 2018cited by 46position: firstdoi
Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort
Psychiatry Research 2018cited by 36position: firstdoi
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition
Current Addiction Reports 2017cited by 137position: firstdoi
Hyperprolactinaemia in first episode psychosis - A longitudinal assessment
Schizophrenia Research 2017cited by 36position: middledoi
The effect of cross-sex hormonal treatment on gender dysphoria individuals' mental health: a systematic review
Neuropsychiatric Disease and Treatment 2016cited by 163position: firstdoi
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study
The Lancet Psychiatry 2016cited by 162position: middledoi
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence
Neuroscience & Biobehavioral Reviews 2016cited by 148position: firstdoi
Substance use, medication adherence and outcome one year following a first episode of psychosis
Schizophrenia Research 2015cited by 101position: firstdoi
Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis
Schizophrenia Bulletin 2015cited by 80position: firstdoi
Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case–control study
Schizophrenia 2015cited by 35position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Sagnik Bhattacharyya · King's College London12 papers (2016–2020)Valeria Mondelli · King's College London5 papers (2015–2020)Philip McGuire · McGill University5 papers (2016–2020)Marta Di Forti · King's College London5 papers (2015–2019)Olesya Ajnakina · King's College London4 papers (2015–2019)Mirella Ruggeri · University of Verona4 papers (2020–2022) · 3 papers (2021–2025)Elena Carra · Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna "Bruno Ubertini"3 papers (2015–2019)Sara Fraietta · King's College London3 papers (2015–2019)John Lally · University College Dublin3 papers (2015–2019)Conrad Iyegbe · Mount Sinai Hospital3 papers (2015–2019)Anthony S. David · Anthony Nolan3 papers (2015–2016)Diego Quattrone · University of London3 papers (2015–2019) · 3 papers (2020–2021)Matthijs G. Bossong · King's College London3 papers (2018–2020)Vincent Giampietro · King's College London2 papers (2020–2020) · 2 papers (2016–2018)Enrico Foglia · University of East London2 papers (2016–2019) · 2 papers (2022–2025)Elizabeth Appiah‐Kusi · King's College London2 papers (2019–2020)